Back to trial details

Intake questionnaire

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Applying to TriHealth Cancer & Blood Institute Research · Cincinnati, Ohio

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with NSCLC (Non-small Cell Lung Cancer)?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Cincinnati for study visits?